From the Helm: CSL’s David Lamont on the biotech giant’s bright future

Jessica Amir
February 20, 2020

In the latest instalment of Bell Direct’s From the Helm series, Jess has a chat with CSL’s CFO David Lamont.

David gives the inside scoop on CSL, the market leader in the blood plasma and vaccine market. Additionally, he explains CSL’s own products, programmes and partnerships, and the steps taken by the medical giant to tackle coronavirus.

Plus, he sheds some light on the unique situation the broader pharmaceuticals industry finds itself in when it comes to new competition, as well as CSL’s future proofing strategy.

Morning Bell 2 July

Jessica Amir
July 2, 2020

Morning Bell 1 July

Jessica Amir
July 1, 2020

Morning Bell 30 June

Jessica Amir
June 30, 2020

Morning Bell 29 June

Jessica Amir
June 29, 2020

Monthly Wrap June 2020

Jessica Amir
June 26, 2020

Morning 26 June

Jessica Amir
June 26, 2020

Morning Bell 25 June

Jessica Amir
June 25, 2020

Morning Bell 24 June

Jessica Amir
June 24, 2020

Morning Bell 23 June

Jessica Amir
June 23, 2020

Morning Bell 22 June

Sally Garrow
June 22, 2020

Weekly Wrap 19 June

Jessica Amir
June 19, 2020